Voyageur Pharmaceuticals (TSXV:VM) Total Liabilities : C$1.39 Mil (As of Aug. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Voyageur Pharmaceuticals Total Liabilities?

Voyageur Pharmaceuticals's Total Liabilities for the quarter that ended in Aug. 2024 was C$1.39 Mil.

Voyageur Pharmaceuticals's quarterly Total Liabilities increased from Feb. 2024 (C$0.99 Mil) to May. 2024 (C$1.08 Mil) and increased from May. 2024 (C$1.08 Mil) to Aug. 2024 (C$1.39 Mil).

Voyageur Pharmaceuticals's annual Total Liabilities declined from Nov. 2021 (C$0.66 Mil) to Nov. 2022 (C$0.63 Mil) but then increased from Nov. 2022 (C$0.63 Mil) to Nov. 2023 (C$0.73 Mil).

Voyageur Pharmaceuticals Total Liabilities Historical Data

The historical data trend for Voyageur Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voyageur Pharmaceuticals Total Liabilities Chart

Voyageur Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Total Liabilities

Get a 7-Day Free Trial

0.85

0.97

0.66

0.63

0.73

Voyageur Pharmaceuticals Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Total Liabilities	Get a 7-Day Free Trial															0.47	0.73	0.99	1.08	1.39

Voyageur Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Voyageur Pharmaceuticals's Total Liabilities for the fiscal year that ended in Nov. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.674	+	(0.04	+	0.014
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	0.73

Total Liabilities	=	Total Assets (A: Nov. 2023 )	-	Total Equity (A: Nov. 2023 )
	=	2.164	-	1.436
	=	0.73

Voyageur Pharmaceuticals's Total Liabilities for the quarter that ended in Aug. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.336	+	(0.04	+	0.014
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	1.39

Total Liabilities	=	Total Assets (Q: Aug. 2024 )	-	Total Equity (Q: Aug. 2024 )
	=	2.334	-	0.945
	=	1.39

Voyageur Pharmaceuticals Total Liabilities Related Terms

Thank you for viewing the detailed overview of Voyageur Pharmaceuticals's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Voyageur Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Voyageur Pharmaceuticals Ltd (TSXV:VM) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

VYYRF:USA

Address

4103B Center Street NW, Suite 800, Calgary, AB, CAN, T2E 2Y6

Website

https://www.voyageurpharmaceuticals.ca

Voyageur Pharmaceuticals Ltd is engaged in acquiring, exploring and developing raw materials for pharmaceutical products.

Executives

Bradley Craig Willis	Director, Senior Officer
Trent Abraham	Director
Charles Littlejohn	10% Security Holder

Voyageur Pharmaceuticals Headlines

No Headlines